Tuesday 9 June 2026, 12:45 – 13:45

Microarray diagnostic platforms and kinetic and quantitative detection

Presented by BioSensing & Diagnostics (BSD) and Sixth Sense Diagnostics (SSDx)

The BioSensing & Diagnostics (BSD) group is part of an application-oriented research institute within Wageningen University & Research. Since 1990, BSD has focused on the development of rapid, multi-analyte diagnostic platforms and their applications, often in close collaboration with, or on behalf of, industry partners.

Examples of such platforms include the microarray-ELISA, which can contain up to 100 spots per well, and the Lateral Flow Microarray Immunoassay (LMIA), capable of accommodating up to 20 spots. In collaboration with HAN University of Applied Sciences, a video-based reader was developed to enable real-time monitoring of signal development at each spot.

To determine kinetic parameters and obtain quantitative results, a Python-based analysis script was created. In partnership with Sixth Sense Diagnostics (SSDx), a startup commercializing this microarray technology, we will present several example assays that have been developed, along with results from ongoing projects.